Moleculin Biotech, Inc. (MBRX) Form S-1/A — Jul 30, 2026
Moleculin Biotech, Inc. has filed an amendment to its Form S-1 registration statement to facilitate a proposed public offering of securities. The company plans to sell up to 4,566,210 shares of common stock, along with accompanying pre-funded warrants and common warrants, at a combined assumed public offering price of $2.19 per unit. Management estimates that the net proceeds from the offering will be approximately $9.1 million, assuming the full sale of the securities.
Key figures
- Offering Price
- 2.19
- Shares Offered
- 4566210
- Placement Agent Fee
- 7%
- Estimated Net Proceeds
- $9.1 million
- Warrant Exercise Price
- $2.19
- Common Warrants Offered
- 13698630
- Shares Outstanding After
- 9902560
- Shares Outstanding Before
- 5336350
- Pre Funded Warrants Offered
- 4566210
Price after filing
Close on the filing date to close N calendar days later (from $1.36). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.